Literature DB >> 191401

Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.

J C Shivers, C A Daniels.   

Abstract

The effect of various anti-immunoglobulin G (IgG) antibodies on the complement-mediated lysis of herpes simplex virus-infected human fibroblasts was determined. IgM rheumatoid factor, a naturally occurring anti-human Fc, inhibited lysis, whereas rabbit anti-human IgG serum potentiated immune cytolysis. We attempted to explain this disparity by determining the effect various classess of anti-IgG's with differing specificities had on complement-mediated lysis. Inhibition of cytolysis occurred with IgM anti-Fc and all of the IgG antiglobulins (anti-IgG, Fab, and Fc). In contrast, IgM anti-Fab enhanced lysis. IgM anti-IgG suppressed immune cytolysis when high concentrations of antiviral serum were incubated with the virus-infected cell, but augmented lysis when low concentrations of anti-herpes simplex virus antibody were exposed to the fibroblasts. The experiments indicated that whether a particular antiglobulin potentiates or inhibits lysis depends on the concentration of antibody bound to the target cells as well as the class and specificity of the antiglobulin exposed to the antibody-coated cell.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191401      PMCID: PMC421393          DOI: 10.1128/iai.15.2.478-484.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The presence of anti-gamma globulin factors in sera of patients with active pulmonary tuberculosis.

Authors:  J M SINGER; C M PLOTZ; F M PERLATA; H C LYONS
Journal:  Ann Intern Med       Date:  1962-04       Impact factor: 25.391

2.  Epidemiology of the sheep cell agglutination test.

Authors:  J BALL; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1961-09       Impact factor: 19.103

3.  The F-II agglutinating factors in serums of patients with non-rheumatic diseases.

Authors:  D S HOWELL; J M MALCOLM; R PIKE
Journal:  Am J Med       Date:  1960-10       Impact factor: 4.965

4.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

5.  The epidemiology of rheumatoid arthritis in Northern Europe.

Authors:  J S LAWRENCE; V A LAINE
Journal:  Proc R Soc Med       Date:  1961-06

6.  Rubella arthritis; report of cases studied by latex tests.

Authors:  R E JOHNSON; A P HALL
Journal:  N Engl J Med       Date:  1958-04-10       Impact factor: 91.245

7.  Observations concerning positive serologic reactions for rheumatoid factor in certain patients with sarcoidosis and other hyperglobulinemic states.

Authors:  H G KUNKEL; H J SIMON; H FUDENBERG
Journal:  Arthritis Rheum       Date:  1958-08

8.  Chromatography of serum proteins in normal and pathologic sera: the distribution of protein-bound carbohydrate and cholesterol, siderophilin, thyroxin-binding protein, B12-binding protein, alkaline and acid phosphatases, radio-iodinated albumin and myeloma proteins.

Authors:  J L FAHEY; P F McCOY; M GOULIAN
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

9.  The effect of rheumatoid factor on the immune lysis of vaccinia virus-infected cells.

Authors:  T G Gipson; C A Daniels
Journal:  Clin Immunol Immunopathol       Date:  1975-05

10.  The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes.

Authors:  J A Markenson; C A Daniels; A L Notkins; J H Hoofnagle; J Gerety; L F Barker
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

View more
  1 in total

1.  Complement activation induced by rabbit rheumatoid factor.

Authors:  R R Meyer; J C Brown
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.